CNMD

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Conmed Corp.

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
CEO
Curt Hartman
Employees
3400
Headquarters

525 French Rd
Utica, New York 13502-5945
Phone: 13156243208
www.conmed.com

News

CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference
Nov 22, 2022 21:05pm

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022. A live audio webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.c


Source:Business Wire
CONMED (CNMD) Investor Presentation - Slideshow (NYSE:CNMD)
Nov 21, 2022 15:06pm

The following slide deck was published by CONMED Corporation in conjunction with this event.


Source:Seeking Alpha
CONMED Withdraws FY22 Guidance Due To Disruptions Associated With Software Implementation
Nov 15, 2022 17:43pm

CONMED Corp (NYSE: CNMD ) is withdrawing its FY22 financial outlook , citing a temporary disruption resulting from implementing new warehouse management software. In recent weeks, the company began implementing new software designed to increase the efficiency and performance of its primary distribution facility. The implementation of this new software created shipping disruptions that lasted longer than initially projected. CONMED … Full story available on Benzinga.com


Source:Benzinga
Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15, 2022 12:52pm

Conmed (CNMD) withdrew its previously-issued FY22 financial outlook because of a temporary disruption resulting from the implementation of software.


Source:Seeking Alpha
CONMED Corporation (CNMD) will benefit from these strategies
Oct 28, 2022 06:56am

CONMED Corporation (NYSE:CNMD) marked $77.88 per share on Thursday, down from a previous closing price of $83.39. While CONMED Corporation has underperformed by -6.61%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CNMD fell by -44.26%, with highs and lows ranging from $159.11 to $73.02, whereas […]


Source:US Post News
CONMED Corporation (CNMD) Q3 2022 Earnings Call Transcript
Oct 27, 2022 01:33am

CONMED Corporation (NYSE:NYSE:CNMD) Q3 2022 Earnings Conference Call October 26, 2022 04:30 p.m.


Source:Seeking Alpha
CONMED Corporation 2022 Q3 - Results - Earnings Call Presentation (NYSE:CNMD)
Oct 26, 2022 23:55pm

The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q3 earnings call.


Source:Seeking Alpha
CONMED Corporation Announces Third Quarter 2022 Financial Results
Oct 26, 2022 20:05pm

CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Sales


Source:Business Wire
Endoscopy Devices Market to Witness Strong Growth by 2030 | CONMED, Karl Storz, Medtronic
Oct 18, 2022 19:12pm

Allied Market Research added new research on Global Endoscopy Devices Market- Global Opportunity Analysis and Industry Forecast, 2022-2030. The Endoscopy Devices market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players.


Source:OpenPR
Sports Medicine Market to Witness Huge Growth by 2028 : Arthrex, ConMed, Depuy Synthes
Oct 18, 2022 16:59pm

Sports Medicine Market 2022-2028 Pune, Maharashtra -- ( SBWIRE ) -- 10/18/2022 -- The Latest research study released by HTF MI "Sports Medicine Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are Arthrex, ConMed, Depuy Synthes, Smith & Nephew & Stryker etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3666215-sports-medicine-market-1 Browse market information, tables and figures extent in-depth TOC on "Sports Medicine Market by Application (Knee, Shoulder, Hip & Spine), by Product Type (, Reconstructive Products, Support, Recovery Products & Accessories), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at sales@htfmarketreport.com At last, all parts of the Sports Medicine Market are quantitatively also subjectively valued to think about the Global just as regional market equally.


Source:SBWire
Domino''s Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday
Oct 14, 2022 11:24am

Wedbush raised Domino''s Pizza, Inc. (NYSE: DPZ ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino''s shares rose 10.4% to close at $333.26 on Thursday. Needham cut the price target on CONMED Corporation (NASDAQ: CNMD ) from $123 to $90. Needham analyst Mike Matson maintained a Buy rating on the stock. CONMED shares rose 3.3% to close at $77.86 on Thursday. B of A … Full story available on Benzinga.com


Source:Benzinga
Top 5 3rd Quarter Trades of MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID
Oct 13, 2022 23:00pm

Related Stocks: WAB , CNMD , CRL , ZD , AJG ,


Source:GuruFocus
CONMED Corporation to Announce Third Quarter 2022 Financial Results on October 26, 2022
Oct 10, 2022 20:05pm

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed f


Source:Business Wire